News

Mar 19, 2012
Rhythmia Medical, Inc. Secures New Financing Round

March 19, 2012- BURLINGTON, MA - Rhythmia Medical, Inc., announced today it has completed a new financing round, led by a leading healthcare corporate investor and participation of existing investors. The funds raised will enable the company to continue its clinical and regulatory program.

"This round is an important milestone for Rhythmia, and further validates the innovation of our technology and the success of our clinical program," said Leon Amariglio, co-chief executive officer of Rhythmia. "We are making great progress towards completing the development of our first generation and are confident in our ability to deliver a best in class technology to the market."

Rhythmia Medical, Inc. is developing a next generation Mapping, Visualization and Navigation system for the treatment of cardiac arrhythmias. Cardiac arrhythmia affects more than 7.5 million people in the United States and Europe, and is a life-threatening condition that can lead to stroke or heart failure. Catheter ablation procedures, currently performed at a rate of over 500,000 per year, represent a greater than $2 billion market with one of the fastest growth rates in medical devices.

About Rhythmia Medical
Founded in 2004, Rhythmia Medical, Inc. is developing a next generation Mapping, Visualization and Navigation system for the treatment of cardiac arrhythmias. The company is conducting human clinical testing outside the US and is working with several of the leading clinicians in this field around the world. The Burlington, Massachusetts-based company has raised financing from a number of investors, including corporate, private and leading medical device venture capital firm Norwich Ventures. The Company has been awarded ISO 13485 certification. Additional information can be found at www.rhythmia.com. You may request Rhythmia's future press releases and additional information by contacting Leon Amariglio at la@rhythmia.com or by telephone at +1 (617) 591 9191 91.



Back to News

 

CONTACT - TERMS OF USE